Users Online: 43
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
QUEST FOR AN ANTIDOTE TO RADIATION TOXICITY - ORIGINAL ARTICLE
Year : 2014  |  Volume : 3  |  Issue : 1  |  Page : 8-12

Role of oral glutamine in alleviation and prevention of radiation-induced oral mucositis: A prospective randomized study


1 Department of Radiotherapy, Medical College, Kolkata, West Bengal, India
2 Department of Radiotherapy, Medical College, Kolkata, West Bengal; Department of Clinical Oncology, Hemalata Hospitals and Research Center, Bhubaneswar, Orissa, India

Correspondence Address:
Aramita Saha
Department of Radiotherapy, Medical College, Kolkata, West Bengal
India
Login to access the Email id

Source of Support: Glutamine packets were supplied free of cost to patients by GLS Pharmaceuticals for the trial after obtaining institutional ethical committee approval, Conflict of Interest: None


DOI: 10.4103/2278-330X.126501

Rights and Permissions

Background: Oral mucositis is the most frequently occurring painful and dose-limiting side-effect of radiation of the head and neck region. Few studies demonstrated that oral glutamine suspension may significantly reduce the duration and severity of objective oral mucositis during radiotherapy. Materials and Methods: A randomized, prospective single institutional case control study was performed between April 2012 and November 2012 comparing the influence of oral glutamine on radiation induced mucositis in head and neck malignancy patients. Seventy biopsy proven patients with head and neck cancer receiving primary or adjuvant radiation therapy were randomized to receive either oral glutamine suspension daily 2h before radiation in the study arm (10 g in 1000 ml of water) (n = 35) or nothing before radiation; control arm (n = 35). Results and Analysis: Total 32 patients (91.43%) in the glutamine arm and total 34 patients (97.15%) developed mucositis. Grade 3 mucositis (14.29%) and grade 4 mucositis (2.86%) in the study arm (who received oral glutamine) were significantly less (P = 0.02 and P = 0.04, respectively) in the glutamine arm. The mean duration of grade 3 or worse mucositis (grade 3 and grade 4) was significantly less (6.6 days vs. 9.2 days) in study arm with P < 0.001. Mean time of onset of mucositis was significantly delayed in patients who took glutamine in comparison to control arm with P < 0.001. Conclusion: Glutamine delays oral mucositis in the head neck cancer patients. Moreover, it reduces the frequency and duration of grade 3 and grade 4 mucositis.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed1908    
    Printed49    
    Emailed1    
    PDF Downloaded798    
    Comments [Add]    
    Cited by others 11    

Recommend this journal